Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case–control study
Open Access
- 1 November 2019
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 121 (11) , 973-978
Abstract
Background: The antihypertensive agent hydrochlorothiazide has been associated with increased risks of non-melanoma skin cancer (NMSC) and possibly some melanoma subtypes. Previous studies were, however, conducted in predominantly Caucasian populations. We therefore examined the association between hydrochlorothiazide and skin cancer risk in an Asian population. Methods: By using Taiwan’s National Health Insurance Research Database (NHIRD), we conducted three separate case–control studies of lip cancer, non-lip non-melanoma skin cancer and melanoma. Cases (n = 29,082) with a first-ever skin cancer diagnoses (2008–2015) were matched 1:10 to population controls. We estimated odds ratios (ORs) associating hydrochlorothiazide use with skin cancer risk by using conditional logistic regression. Results: Hydrochlorothiazide use showed no overall association with any of the three outcomes: ORs for high cumulative use of HCTZ (≥50,000 mg) were 0.86 (95% CI 0.09–7.81) for lip cancer, 1.16 (95% CI 0.98–1.37) for non-lip NMSC and 1.07 (95% CI 0.65–1.76) for melanoma. There was some evidence of a dose–response pattern for non-lip NMSC, with an OR of 1.66 (95% CI 0.82–3.33) for 100,000–149,999 mg of HCTZ. The null findings were robust across subgroup and sensitivity analyses. Conclusion: Use of HCTZ appears safe in terms of skin cancer risk in an Asian population.Keywords
This publication has 27 references indexed in Scilit:
- Photosensitizing Agents and the Risk of Non-Melanoma Skin Cancer: A Population-Based Case–Control StudyJournal of Investigative Dermatology, 2013
- Antihypertensive Drugs and Lip Cancer in Non-Hispanic WhitesArchives of internal medicine (1960), 2012
- The predictive value of ICD-10 diagnostic coding used to assess Charlson comorbidity index conditions in the population-based Danish National Registry of PatientsBMC Medical Research Methodology, 2011
- Photosensitizing Medication Use and Risk of Skin CancerCancer Epidemiology, Biomarkers & Prevention, 2010
- The Asian Dermatologic PatientAmerican Journal of Clinical Dermatology, 2009
- Chronic Diseases Requiring Hospitalization and Risk of Non-Melanoma Skin Cancers—A Population Based Study from DenmarkJournal of Investigative Dermatology, 2008
- HIV and Skin CancerDermatologic Clinics, 2006
- A marker for Stevens–Johnson syndromeNature, 2004
- Drug-Induced Cutaneous PhotosensitivityDrug Safety, 2002
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987